Statistically significant lower risk is seen for mortality and recovery. 3 studies from 3 independent teams in 3 countries show significant improvements.
Meta analysis using the most serious outcome reported shows 17% [-3‑34%] lower risk, without reaching statistical significance. Results are similar for peer-reviewed studies and worse for Randomized Controlled Trials.
6 RCTs with 1,092 patients have not reported results (up to 3 years late).
No treatment or intervention is 100% effective. All practical, effective, and safe means should be used based on risk/benefit analysis. Multiple treatments are typically used in combination, and other treatments are significantly more effective.
All data to reproduce this paper and sources are in the appendix.
Covid Analysis et al., Sep 2024, preprint, 1 author.
